Research
Randomised prostate cancer screening trial: 20 year follow-up
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d1539 (Published 31 March 2011) Cite this as: BMJ 2011;342:d1539
Related articles
- Views & Reviews Published: 01 June 2011; BMJ 342 doi:10.1136/bmj.d3421
- Research Published: 01 March 2012; BMJ 344 doi:10.1136/bmj.e900
- Research Published: 05 September 2018; BMJ 362 doi:10.1136/bmj.k3519
See more
- Clinicians raise concerns over pilot of blood test for multiple cancersBMJ October 02, 2023, 383 p2268; DOI: https://doi.org/10.1136/bmj.p2268
- Ovarian cancer: NICE recommends expanding availability of genetic testingBMJ September 15, 2023, 382 p2111; DOI: https://doi.org/10.1136/bmj.p2111
- Authors’ reply to Oke and WelchBMJ September 13, 2023, 382 p2095; DOI: https://doi.org/10.1136/bmj.p2095
- Breast cancer: conflating case fatality with mortalityBMJ September 12, 2023, 382 p2086; DOI: https://doi.org/10.1136/bmj.p2086
- Cancer charity questions NHS England’s claim that waiting times are improvingBMJ September 04, 2023, 382 p2028; DOI: https://doi.org/10.1136/bmj.p2028
Cited by...
- UKCTOCS Update: Applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis
- Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
- Recommendations on screening for prostate cancer with the prostate-specific antigen test
- Prostate Cancer, Version 2.2014
- Serum microRNAs as Biomarkers in Patients Undergoing Prostate Biopsy: Results from a Prospective Multi-Center Study
- Radical prostatectomy does not improve survival compared to observation for localised prostate cancer in a prospective randomised trial
- Prostate-specific antigen screening can be beneficial to younger and at-risk men
- Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines
- Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion
- Screening and cervical cancer cure: population based cohort study
- Prostate cancer screening has no effect on prostate cancer specific mortality over 20 years of follow-up of Swedish men
- Report bias favours screening
- Underscreened and undertreated
- Study raises five questions
- What is mortality denominator?
- Study has major shortcomings
- Evidence of overdiagnosis
- Yet Another Prostate Cancer Screening Study